Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis

Digestive and Liver Disease

Volumn 43, Issue 4, 2011, Pages 314-318

  Romanelli, Roberto Giulio ^a   Laffi, Giacomo ^a   Vizzutti, Francesco ^a   Del Bene, Riccarda ^a   Marra, Fabio ^a   Caini, Patrizio ^a   Guerra, Cristina Tosti ^a   La Villa, Giorgio ^a   Barletta, Giuseppe ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cirrhosis; Echocardiography; Liver disease; Systemic haemodynamics; Urotensin II

Indexed keywords

CREATININE; UROTENSIN II;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HEMODYNAMIC MONITORING; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC CIRCULATION; SYSTEMIC HAEMODYNAMICS;

ADULT; AGED; ALDOSTERONE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RENIN; UROTENSINS;

EID: 79952192332     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.08.012     Document Type: Article

References (23)

1. Zhu Y.C., Zhu Y.Z., Moore P.K. The role of urotensin II in cardiovascular and renal physiology and diseases. Br J Pharmacol 2006, 148:884-901.
2. Gruson D., Rousseau M.F., Ahn S.A., et al. Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers. Peptides 2006, 27:1527-1531.
3. Ng L.L., Loke I., O'Brien R.J., et al. Plasma urotensin in human systolic heart failure. Circulation 2002, 106:2877-2880.
4. Richards A.M., Nicholls M.G., Lainchbury J.G., et al. Plasma urotensin II in heart failure. Lancet 2002, 360:545-546.
5. Russell F.D., Meyers D., Galbraith A.J., et al. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol 2003, 285:H1576-H1581.
6. Cheung B.M., Leung R., Man Y.B., et al. Plasma concentration of urotensin II is raised in hypertension. J Hypertens 2004, 22:1341-1344.
7. Totsune K., Takahashi K., Arihara Z., et al. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci 2003, 104:1-5.
8. Totsune K., Takahashi K., Arihara Z., et al. Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with type 2 diabetes mellitus: association with progress of diabetic nephropathy. Peptides 2004, 25:1809-1814.
9. Totsune K., Takahashi K., Arihara Z., et al. Role of urotensin II in patients on dialysis. Lancet 2001, 358:810-811.
10. Heller J., Schepke M., Neef M., et al. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. J Hepatol 2002, 37:767-772.
11. Kemp W., Krum H., Colman J., et al. Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension. Liver Int 2007, 27:1232-1239.
12. Kemp W., Krum H., Colman J., et al. Urotensin II is a relevant vasoactive mediator of cirrhotic portal hypertension in humans. Hepatology 2006, 44:202A.
13. Kemp W., Kompa A., Phrommintikul A., et al. Urotensin II modulates hepatic fibrosis and portal haemodynamic alterations in rats. Am J Physiol Gastrointest Liver Physiol 2009, 297:G762-G767.
14. Kemp W., Roberts S., Krum H. Increased circulating urotensin II in cirrhosis: potential implications in liver disease. Peptides 2008, 29:868-872.
15. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
16. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-9.
17. Arroyo V., Ginès P., Gerbes A.L., et al. International Ascites Club. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996, 23:164-175.
18. Gentilini P., Romanelli R.G., Laffi G., et al. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999, 30:632-638.
19. Laffi G., Barletta G., La Villa G., et al. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. Gastroenterology 1997, 113:891-898.
20. La Villa G., Fronzaroli C., Lazzeri C., et al. Cardiovascular and renal effects of low-dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab 1994, 78:1166-1171.
21. Tarquini R., Masini E., La Villa G., et al. Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. Am J Gastroenterol 2009, 104:891-897.
22. Trebicka J., Leifeld L., Hennenberg M., et al. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology 2008, 47:1264-1276.
23. Tran L., Kompa A.R., Kemp W., et al. Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats. Am J Physiol Heart Circ Physiol 2010, 298:H608-H613.